Methylation of GSTP1 is frequently observed in prostate cancer tissue but is rare in normal prostate tissue, which suggests that methylated GSTP1 in cfDNA may serve as a biomarker for prostate cancer diagnosis. The gene discussed is GSTP1; the disease is prostate carcinoma.